Haluk Tezcan, MD

Kootenai Cancer CenterPost Falls, Idaho - 83854 |
- CLINICAL TRIALS 3
- CONDITIONS12
- INTERVENTIONS4
- SINCE2008

Study of Molecular Response in Adult Patients on Nilotinib With Philadelphia Chromosome Positive Chronic Myelogenous Leukemia (Ph+ CML) in Chronic Phase and a Suboptimal Molecular Response to Imatinib
March 2008 - December 2016

Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients
May 2010 - November 2012

Phase III Lucanix Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
July 2008 - October 2011
Breast Neoplasms
Lung Neoplasms
Leukemia
Neoplasms
Neoplasm Metastasis
Leukemia, Myeloid
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Carcinoma
Carcinoma, Non-Small-Cell Lung
Philadelphia Chromosome
Chromosome Aberrations
Chronic Disease
Zoledronic Acid
Nilotinib
Placebo Comparator
Lucanix™



